CG Stock Recent News

Carlyle Group offers value with shares 20% below highs, strong AUM growth, and a secure 3.2% dividend yield. Fee-based earnings are highly predictable, with $26B pending fee-earning AUM and credible 6% growth guidance for the year. Diversification into credit, insurance, and secondary markets boosts recurring revenue, with $99B in perpetual fee-earning AUM.

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”) today reminds all stockholders to promptly tender their shares into the tender offer by Carlyle and SK Capital to purchase all outstanding shares of bluebird common stock by 11:59 p.m. Eastern on May 29, 2025. Stockholders that hold shares of bluebird through a broker or other nominee may be subject to a processing cutoff that is prior to the tender deadline, so it is important to act now. Additi.

Axcap signs definitive Mineral Property Purchase Agreement acquiring the Newton Gold Project located in British Columbia, Canada The Newton Gold Project has an inferred mineral resource containing 842,900 oz of Au, and 4,506,100 oz of Ag with an average grade of 0.64 g/t Au 1 Toronto, Ontario--(Newsfile Corp. - May 26, 2025) - Axcap Ventures Inc. (CSE: AXCP) (OTC: GARLF) ("Axcap") and Carlyle Commodities Corp. (CSE: CCC) (FSE: BJ4) (OTC: CCCFF) ("Carlyle") are pleased to announce that they have entered into a definitive Mineral Property Purchase Agreement dated May 23, 2025 (the "Agreement") pursuant to which Axcap will acquire a 100% interest in Carlyle's Newton Gold Project (the "Newton Project"), located in British Columbia, Canada (the "Transaction"). Newton Project Summary The Newton Property is located approximately 108 km west-southwest of Williams Lake, British Columbia and consists of 62 claims comprising an area of approximately 23,003 ha.

Jeff Currie, Carlyle chief strategy officer of energy pathways, joins CNBC's 'Squawk on the Street' to discuss outlooks on energy.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”) announced today the pricing of its underwritten public offering by two of its stockholders (the “Selling Stockholders”), affiliates of The Carlyle Group Inc. and GIC, of an aggregate of 30,000,000 shares of the Company's common stock, par value $0.01 per share (“Common Stock”), at a price to the public of $28.00 per share. The Selling Stockholders will receive all of the net proceeds from this.

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) today announced its financial results for its second quarter ending March 31, 2025. The full detailed presentation of the Fund's second quarter 2025 financial results can be viewed on the Fund's website (carlylecreditincomefund.com/investor-dashboard).

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”) announced today that two of its stockholders (the “Selling Stockholders”), affiliates of The Carlyle Group Inc. and GIC, intend to offer for sale in an underwritten secondary offering an aggregate of 30,000,000 shares of the Company's common stock, par value $0.01 per share (the “Common Stock”), pursuant to the Company's shelf registration statement on Form S-1 filed with the Securities and Exc.

Establishes nitinol input tube operation to support premium, implant-grade tubing initiative and strengthen supply chain resilience NASHUA, N.H. , May 19, 2025 /PRNewswire/ -- Resonetics® announced today that it has acquired the nitinol gun drilling operations and related assets of Medical Component Specialists' (MCS) New Boston, NH facility.

SOMERVILLE, Mass.--(BUSINESS WIRE)--As previously announced on May 14, 2025, Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), have amended their definitive agreement pursuant to which Carlyle and SK Capital will purchase all of the outstanding shares of bluebird. The parties have issued the following updated instructions for stockholders to tender their shares into the offer. Updated Instructions for Stockholders: Contr.

Shares of bluebird bio Inc (NASDAQ:BLUE) surged 50% on Wednesday after the gene therapy developer announced an amended acquisition agreement with private equity firms Carlyle and SK Capital, offering shareholders a higher upfront cash payout. The revised deal includes a $5 per share cash offer, replacing a previous bid that had offered $3 per share upfront and a contingent value right (CVR) of $6.84 per share, payable if certain sales milestones were met.